Why is important for minority populations to take part of cancer clinical trials?

Warning Icon This event is in the past.

Date: November 10, 2020
Time: 1:00 p.m. - 2:00 p.m.
Location: Zoom
Category: Lecture

Win a drawing for $25 by attending Karamanos Cancer Institute's first ever community grand rounds event. Unlike traditional grand rounds, these are open to members of the community. 

So what are cancer clinical trials and why is participation so important? Clinical trials are important to discovering new treatments and determining which forms of therapy are best for certain illnesses and groups of people. However, without representation from diverse populations, one cannot generalize the findings to all members of the population to see if treatments are safe and effective. Side effects and treatment responses may vary by age, race, ethnicity, and gender. Racial and ethnic minorities — particularly African Americans — bear the greatest cancer burden in the US. Yet,  83% of clinical trial participants are white, while only 6 % are African American and


Join us on Tuesday, Nov 10th, from 1-2 pm and listen to Dr. Anthony Shields, Associate Center Director for Clinical Sciences of Karmanos Cancer Institute, talk about the facts of cancer clinical trials and how to get involved.

Register for this interactive educational sesson today!

Contact

Kris Johns
313-473-9714
johnsk@karmanos.org

Cost

Free

Audience

Alumni, Community, Current students, Parents, Staff